Cost-effectiveness analysis of pharmaceuticals: its informational content and an example.
The importance of cost-effectiveness analysis within the health care sector will increase. This is due to changes in the health care sector where there is an emphasis on improving the efficiency. The changes will influence the incentive structure and, subsequently, the demand for reliable managerial information. Cost-effectiveness analysis of pharmaceuticals is a good example of the state-of-the-art of cost-effectiveness applied to health care. A study on the cost-effectiveness of prophylaxis against infection in total joint replacement is presented as an example of an economic evaluation of pharmaceuticals.
Hertzman
P
P
IHE, Swedish Institute for Health Economics, Lund.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis / Q000379:methods*; D004358:Drug Therapy / Q000191:economics*; D006622:Hip Prosthesis; D006801:Humans; D010043:Outcome and Process Assessment, Health Care / Q000191:economics*; D012086:Reoperation / Q000191:economics; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control
D000900:Anti-Bacterial Agents